TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Left Ventricular Mass Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of NICU-based rehabilitation program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hepatic venous flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with positive wheal responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of Plagiocephaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orexin A concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of children developing new caries in deciduous molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of deciduous molars developing new caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations of retinal nerve fibre layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fibroid volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Modified Fatigue Impact Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in UCLA scale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in QuickDash scale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Atrial arrhythmias incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % ventricular pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: response in HAMDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of older adult EMS patients requiring TBI-related trauma center care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity, specificity and overall classification accuracy of neurologic scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Reported Use of Evidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of autonomic index with propofol induction-related sympathetic and parasympathetic imbalance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Presentation Rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Transfer to Hospital Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Screening/Baseline in Social Responsiveness Scale (SRS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Time to PSA relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative infection requiring return to operating room
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentration of Presepsin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the Receiver-operating characteristic Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Serious Adverse Device Effects (SADES)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective surgical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale (VAS) for Leg Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Device Related (MDR) Complications
Endpoint domain: Adverse events/effects
Primary endpoint: adherence measured by pharmacy refills
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: acute myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cerebral stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Volume Transfer Coefficient of Contrast Agent Across the Capillary Walls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Plasma Volume and Extravascular/Extracellular Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial Area Under the DCE-MRI Contrast Agent Concentration Time Curve After 60 Seconds (IAUC60)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole Tumor Volume and Enhancing Tumor Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Decreased plasma levels of Aβ peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased plasma levels of tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased plasma levels of glial fibrillary acidic protein (GFAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Cells in Anterior Chamber of the Study Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Pain in Study Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of geographic atrophy size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to stent occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Perceived Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Loss of Therapeutic Response
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in ODI score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Cell-associated HIV DNA (Ca-DNA) Levels Per 10^6 T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Cell-associated HIV DNA (Ca-DNA) Levels Per 10^6 Effector Memory CD4+ T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Cell-associated Intact HIV DNA (Ca-iDNA) Levels Per 10^6 T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decision to prescribe celecoxib
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in unfolded protein response markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staging accuracy of MSCT and MRI in Gastric Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity and specificity of diagnostic techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Modified MI and BDS
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of Modified MI and BDS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in GERD Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Whole body fat free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MRL and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of MRL and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of MRL and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of circulating tumor DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Area Under the Plasma Analyte Concentration-time Curve From the Time of 0 to one Week Post-doses [(AUC)0-168h]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Analyte Concentration-time Curve From Time 0 to Time of the Last Observed Quantifiable Concentration [(AUC)0-last]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Analyte Concentration-Time Curve From Time 0 to Infinite Time [(AUC)0-infinity]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with superficial wound disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Subjects With Confirmed Herpes Zoster (HZ) Cases
Endpoint domain: Adverse events/effects
Primary endpoint: adherence to exclusive breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adherence to ARV prophylaxis or ART regimens
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Percentage Change in Fasting Body Weight From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Subjects Who Maintained Their run-in Fasting Weight Loss From Week 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Subjects Who Lost More Than or Equal to 5% of Fasting Body Weight From Week 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New or Recurrent Disease Progression Events
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in the dual task cost to gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the dual task cost to standing postural sway speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Short Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Trail Making Test B - A
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of long-term virological outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of long-term immunological outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Morbidity and mortality outcomes
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge using the Breast Cancer Decision Quality Instrument
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization due to SARS-CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Overall Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to Adenosine Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of isoflavones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Climb 4 Stairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent serious adverse events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of drug-related TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of drug-related TESAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute Walking Distance (AWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With a Solicited Injection-site Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With a Solicited Systemic Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Metabolic Clearance of D6-25(OH)D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of posincisional hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rectus Femoris Cross Sectional Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incident Atherosclerotic Cardiovascular Disease (ASCVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Illness Perception - Current Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Illness Perception - Duration of Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Event free interval
Endpoint domain: Mortality/survival
Primary endpoint: Subjective hearing threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline visceral fat area at L4 at 12-week (CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Score on Clinician Administered PTSD Scale for the DSM-5 (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Score on the PTSD Check List-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Score on the Tinnitus Functional Index (TFI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Glycosylated Hemoglobin (Hba1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rheological measurements (viscosity and elasticity) in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTc Interval Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of Vessels Transected Requiring Intra-Operative Hemostatic Interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax of encapsulated and free doxorubicin in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (0-t) of encapsulated and free doxorubicin in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (0-inf) of encapsulated and free doxorubicin in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned Medical readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Emergency Department attendance rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 30 days graft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarker levels in cerebrospinal fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Enrolled in Part B With an Emergency Department Visit or a Hospitalization for Pain Within 24 Hours of Completion of Each Yoga Session
Endpoint domain: Adverse events/effects
Primary endpoint: change of max LCBI(4mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with reduced respiratory chain enzyme levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Response to vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hospital acquired infection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Adverse Drug Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of immunological tolerance to cow's milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunologic Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Body Dysmorphic Disorder Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-Mouth Gingivitis Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-Mouth Dental Plaque Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of pulmonary embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of Skin Cancer Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thigh Intraepidermal Nerve Fiber Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: anterior chamber cell score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: International Standards for the Neurological Classification of Spinal Cord Injury Classification scores (ISNCSCI ASIA chart)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spinal Cord Independence Measure (SCIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Berg Balance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Antibody Level ≥0.35μg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Reporting Pre-Specified Local Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Reporting Pre-Specified Systemic Events (Infant Series)
Endpoint domain: Adverse events/effects
Primary endpoint: safety and adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Premature Ovarian Insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Absence of antegrade radial artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in dental anxiety assessed by measuring the cognitive and behavioral aspects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in dental anxiety assessed by measuring the physiological aspect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients at maximum tolerated dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal value of vascular index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: limiting weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma pharmacokinetics parameters of amlodipine and rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability and function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Isometric Force Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Endpoint on Patient Clinical Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of loss of orthodontic brackets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Integrated low frequency reactance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of digestive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of digestive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Schirmer's Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye Dryness Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in coagulation profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants With an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Time-weighted Average Across 24 Hours (TWA0-24hrs) cSBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Time-weighted Average Across 24 Hours (TWA0-24hrs) AIx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Qualitative Spleen Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Howell-Jolly Bodies (HJB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUC of postoperative plasma released hsTnI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes